Since the discovery of STAT3 SH2 domain hot-spot mutations in T-LGL leukemia cells, STAT3 hyper-activation could be explained in 30–40% of cases [22]. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.